Literature DB >> 19575018

Cyclin D1 promotes anchorage-independent cell survival by inhibiting FOXO-mediated anoikis.

L Gan1, P Liu, H Lu, S Chen, J Yang, J B McCarthy, K E Knudsen, H Huang.   

Abstract

O-class forkhead box (FOXO) transcription factors are critical regulators of diverse cellular processes, including apoptosis, cell-cycle arrest, DNA damage repair and oxidative stress resistance. Here, we show that FOXO1 and FOXO3a have an essential function in promoting cell detachment-induced anoikis, resistance to which is implicated in cancer development and metastasis. In contrast, the oncoprotein cyclin D1 inhibits anoikis. We further show that cyclin D1 interacts with FOXO proteins and impedes their transcriptional regulatory and anoikis-promoting functions. This effect of cyclin D1 requires its transcription repression domain but is independent of cyclin-dependent kinases CDK4 and CDK6. Moreover, we show that cancer-derived mutants of cyclin D1 are much more stable than wild-type cyclin D1 under anchorage-independent conditions and possess a greater antagonistic effect on FOXO-regulated anoikis and anchorage-independent growth of cancer cells. These data suggest that cyclin D1 may have a critical function in tumorigenesis and cancer metastasis by inhibiting the anoikis-promoting function of FOXO proteins.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19575018      PMCID: PMC3071150          DOI: 10.1038/cdd.2009.86

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  39 in total

1.  Protection against anoikis and down-regulation of cadherin expression by a regulatable beta-catenin protein.

Authors:  Zhigang Weng; Mei Xin; Lourdes Pablo; Dorre Grueneberg; Margit Hagel; Gerard Bain; Thomas Müller; Jackie Papkoff
Journal:  J Biol Chem       Date:  2002-03-19       Impact factor: 5.157

2.  Specific protection against breast cancers by cyclin D1 ablation.

Authors:  Q Yu; Y Geng; P Sicinski
Journal:  Nature       Date:  2001-06-28       Impact factor: 49.962

3.  Overexpression of cyclin D1 is associated with metastatic prostate cancer to bone.

Authors:  M Drobnjak; I Osman; H I Scher; M Fazzari; C Cordon-Cardo
Journal:  Clin Cancer Res       Date:  2000-05       Impact factor: 12.531

4.  A transcription-independent function of FOXO1 in inhibition of androgen-independent activation of the androgen receptor in prostate cancer cells.

Authors:  Ping Liu; Shangwei Li; Lu Gan; Timothy P Kao; Haojie Huang
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

5.  Specific lentiviral shRNA-mediated knockdown of cyclin D1 in mantle cell lymphoma has minimal effects on cell survival and reveals a regulatory circuit with cyclin D2.

Authors:  M Klier; N Anastasov; A Hermann; T Meindl; D Angermeier; M Raffeld; F Fend; L Quintanilla-Martinez
Journal:  Leukemia       Date:  2008-08-07       Impact factor: 11.528

6.  Cancer. Addiction to oncogenes--the Achilles heal of cancer.

Authors:  I Bernard Weinstein
Journal:  Science       Date:  2002-07-05       Impact factor: 47.728

7.  CDK1 promotes cell proliferation and survival via phosphorylation and inhibition of FOXO1 transcription factor.

Authors:  P Liu; T P Kao; H Huang
Journal:  Oncogene       Date:  2008-04-14       Impact factor: 9.867

8.  FOXO proteins regulate tumor necrosis factor-related apoptosis inducing ligand expression. Implications for PTEN mutation in prostate cancer.

Authors:  Vijayanand Modur; Rakesh Nagarajan; B Mark Evers; Jeffrey Milbrandt
Journal:  J Biol Chem       Date:  2002-09-25       Impact factor: 5.157

9.  Localization determines function: N-terminally truncated NS5A fragments accumulate in the nucleus and impair HCV replication.

Authors:  Daniel Sauter; Kiyoshi Himmelsbach; Malte Kriegs; Monica Carvajal Yepes; Eberhard Hildt
Journal:  J Hepatol       Date:  2009-01-31       Impact factor: 25.083

10.  Multiple oncogenic pathway signatures show coordinate expression patterns in human prostate tumors.

Authors:  Chad J Creighton
Journal:  PLoS One       Date:  2008-03-19       Impact factor: 3.240

View more
  18 in total

Review 1.  c-Myc induction of programmed cell death may contribute to carcinogenesis: a perspective inspired by several concepts of chemical carcinogenesis.

Authors:  Chenguang Wang; Yanhong Tai; Michael P Lisanti; D Joshua Liao
Journal:  Cancer Biol Ther       Date:  2011-04-01       Impact factor: 4.742

Review 2.  The role of vitamin D in hepatic metastases from colorectal cancer.

Authors:  E Shaw; N Massaro; N T Brockton
Journal:  Clin Transl Oncol       Date:  2017-08-11       Impact factor: 3.405

3.  AKT-phosphorylated FOXO1 suppresses ERK activation and chemoresistance by disrupting IQGAP1-MAPK interaction.

Authors:  Chun-Wu Pan; Xin Jin; Yu Zhao; Yunqian Pan; Jing Yang; R Jeffrey Karnes; Jun Zhang; Liguo Wang; Haojie Huang
Journal:  EMBO J       Date:  2017-03-09       Impact factor: 11.598

4.  Cyclin D1 is a selective modifier of androgen-dependent signaling and androgen receptor function.

Authors:  Clay E S Comstock; Michael A Augello; Matthew J Schiewer; Jason Karch; Craig J Burd; Adam Ertel; Erik S Knudsen; Walter J Jessen; Bruce J Aronow; Karen E Knudsen
Journal:  J Biol Chem       Date:  2011-01-05       Impact factor: 5.157

5.  FOXO1 inhibits Runx2 transcriptional activity and prostate cancer cell migration and invasion.

Authors:  Haijun Zhang; Yunqian Pan; Li Zheng; Chungyoul Choe; Bruce Lindgren; Eric D Jensen; Jennifer J Westendorf; Liang Cheng; Haojie Huang
Journal:  Cancer Res       Date:  2011-04-19       Impact factor: 12.701

6.  FOXO1 binds to the TAU5 motif and inhibits constitutively active androgen receptor splice variants.

Authors:  Laura R Bohrer; Ping Liu; Jian Zhong; Yunqian Pan; James Angstman; Lucas J Brand; Scott M Dehm; Haojie Huang
Journal:  Prostate       Date:  2013-02-06       Impact factor: 4.104

Review 7.  Non-canonical functions of cell cycle cyclins and cyclin-dependent kinases.

Authors:  Per Hydbring; Marcos Malumbres; Piotr Sicinski
Journal:  Nat Rev Mol Cell Biol       Date:  2016-04-01       Impact factor: 94.444

8.  Cyclin D1 affects epithelial-mesenchymal transition in epithelial ovarian cancer stem cell-like cells.

Authors:  Jie Jiao; Lu Huang; Feng Ye; Minfeng Shi; Xiaodong Cheng; Xinyu Wang; Dongxiao Hu; Xing Xie; Weiguo Lu
Journal:  Onco Targets Ther       Date:  2013-06-20       Impact factor: 4.147

9.  Trop2 expression contributes to tumor pathogenesis by activating the ERK MAPK pathway.

Authors:  Rafael Cubas; Sheng Zhang; Min Li; Changyi Chen; Qizhi Yao
Journal:  Mol Cancer       Date:  2010-09-21       Impact factor: 27.401

10.  Trop-2 protein overexpression is an independent marker for predicting disease recurrence in endometrioid endometrial carcinoma.

Authors:  Eliana Bignotti; Laura Zanotti; Stefano Calza; Marcella Falchetti; Silvia Lonardi; Antonella Ravaggi; Chiara Romani; Paola Todeschini; Elisabetta Bandiera; Renata A Tassi; Fabio Facchetti; Enrico Sartori; Sergio Pecorelli; Dana M Roque; Alessandro D Santin
Journal:  BMC Clin Pathol       Date:  2012-11-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.